The pilot will use the fast-acting drug Fibrinogen, which has shown promising results in a Welsh study for its clinical benefits ...
A MATERNITY unit has received additional funding to launch a two-year pilot to help revolutionise care for birthing mothers, ...
Department of Chemistry, University of Michigan, 930 North University Avenue Ann Arbor, Michigan 48103, United States ...
Preeclampsia, a pregnancy-specific condition marked by hypertension and proteinuria, has been identified as a risk factor for postpartum depression ...
fncls.ssp?fn=show_t_gif&application_id=2063989&application_name=news&site_id=newmediawire~~~ce31e09e-58c0-4982-8e07-f69a10de079e ...
Spanish firm Grifols (MCE: GRF) has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US Food and Drug Administration (FDA). Grifols claims that its ...